4//SEC Filing
Kamal Fariborz 4
Accession 0001567619-21-005968
CIK 0001650648other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:06 PM ET
Size
5.6 KB
Accession
0001567619-21-005968
Insider Transaction Report
Form 4
Kamal Fariborz
President & COO
Transactions
- Award
Stock Option (Right to Buy)
2021-03-08+60,000→ 60,000 totalExercise: $41.66Exp: 2031-03-07→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 8, 2021 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.
Documents
Issuer
4D Molecular Therapeutics Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001834020
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:06 PM ET
- Size
- 5.6 KB